• Explore /
  • Videos & Slides
  • / Identification of good and poor prognosis HPV associated oropharyngeal cancer based on CD103 immune cell expression in patients treated with cetuximab and radiotherapy on TROG 12.01 and De-ESCALaTE randomized trials.

Identification of good and poor prognosis HPV associated oropharyngeal cancer based on CD103 immune cell expression in patients treated with cetuximab and radiotherapy on TROG 12.01 and De-ESCALaTE randomized trials.

Abstract Video & Slides

Presenter

null

Danny Rischin, MD

Department of Medical Oncology, Peter MacCallum Cancer Centre and the Sir Peter MacCallum Department of Oncology, University of Melbourne

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Videos & Slides Details

Meeting

2021 ASCO Annual Meeting

Session Type

Clinical Science Symposium

Session Title

Virally Induced Cancers: Epidemiology and Biomarker-Guided Care

Track

Special Sessions

Sub Track

Local-Regional Disease

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 109)

DOI

10.1200/JCO.2021.39.15_suppl.109

Abstract #

109

Abstract Disclosures

Similar Videos & Slides

Speaker: Nancy Y. Lee, MD

Speaker: Ari Joseph Rosenberg, MD

Videos & Slides

2022 Best of ASCO Hollywood

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Speaker: Arsen Osipov, MD

Speaker: Ari Rosenberg, MD